Prevalence of human papillomaviruses in self-collected samples among women attending antenatal care in Ethiopia: a cross-sectional study.

Africa Ethiopia HPV test cervical cancer prevention cervical cancer screening population-based pregnancy

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2024
Historique:
received: 05 03 2024
medline: 18 10 2024
pubmed: 18 10 2024
entrez: 18 10 2024
Statut: epublish

Résumé

Cervical cancer is the second most commonly diagnosed cancer in women in Ethiopia. However, data are limited on the prevalence of human papillomavirus (HPV) genotypes. Self-sampled vaginal lavages were obtained consecutively from 783 women attending 7 health facilities across Ethiopia. Genotype prevalence was assessed by Multiplex-Papillomavirus-Genotyping which detects and individually identifies 51 genotypes and 3 subtypes. Genotype-specific prevalence was described and associations with known risk factors were analysed. The overall HPV prevalence (age range 18-45) was 33.1% (95% confidence interval (CI) 29.8-36.4). The prevalence of HPV was different in the rural and urban population with 17.6% (95%CI 11.6-23.7) and 36.8% (95%CI 33.1-40.6) (p < 0.001 chi-square test), respectively. The most common high-risk types were HPV 16 (6.6%), followed by HPV 52 (4.3%), 51 and 39 (both 2.9%). Urban women compared to rural women had a higher risk of being HPV positive (odds ratio 2.36 (95% CI 1.47-3.79; p < 0.001). Age at sexual debut ≤15 years and polygamous husband (in urban women) also increased the risk of being HPV positive nearly two-fold. The high prevalence of hr-HPV in Ethiopian women in the reproductive age group shows the need for screening programs. The nonavalent HPV vaccine covers the most prevalent hr-HPV genotypes as found in this study and can therefore be used effectively. Since antenatal care is the best-utilised health service, implementing self-sampled vaginal lavage could be an opportunity for screening in this age group. Screening algorithms and triage still need to be defined to avoid over-treatment in these women.

Identifiants

pubmed: 39421164
doi: 10.3332/ecancer.2024.1739
pii: can-18-1739
pmc: PMC11484669
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1739

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors have no conflict of interest.

Auteurs

Isabel Runge (I)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Johanna M A Klein (JMA)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Ann-Katrin Pannen (AK)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Semaw Abera (S)

Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Department of Radiation Oncology, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06108 Halle (Saale), Germany.
School of Public Health, College of Health Sciences, Mekelle University, Mekele 0231, Ethiopia.
Kilte Awlaelo - Health and Demographic Surveillance Site, College of Health Sciences, Mekelle University, Mekele 0231, Ethiopia.

Tariku Wakuma (T)

Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Aira Hospital, Aira, Ethiopia.

Yirgu Gebrehiwot (Y)

Department of Obstetrics and Gynaecology, College of Health Sciences, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Susanne Unverzagt (S)

Institute of General Practice and Family Medicine, Center of Health Sciences, Martin-Luther-University Halle-Wittenberg, 06097 Halle (Saale), Germany.

Andreas Wienke (A)

Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Christoph Thomssen (C)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Andreas M Kaufmann (AM)

Clinic for Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin Institute of Health, Campus Virchow Klinikum, Humboldt-Universität zu Berlin, 10117 Berlin, Germany.

Ahmedin Jemal (A)

American Cancer Society, Atlanta, GA 30303, USA.

Tamrat Abebe (T)

Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Department of Microbiology, Immunology & Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Dana Holzinger (D)

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Tim Waterboer (T)

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Daniela Höfler (D)

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Adamu Addissie (A)

Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa 1000, Ethiopia.

Eva Johanna Kantelhardt (EJ)

Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.
Global Health Working Group, Institute of Medical Epidemiology, Biometrics and Informatics, Martin-Luther-University Halle-Wittenberg, 06108 Halle, Germany.

Classifications MeSH